TNFRSF4 and breast cancer: No profound differences were observed between patients and HD, even if biometrical analysis revealed a small statistically significant difference for HVEM in T cells of CC and OX40 in T cells of BC patients compared to HD (BC, p = 0.0125, ordinary one-way ANOVA with subsequent Dunnett’s multiple comparisons test; CC, p = 0.0206, Kruskal-Wallis test with subsequent Dunnett’s multiple comparisons test).